NCT02960945View on ClinicalTrials.gov

Open-Label Crossover Study Comparing CTP-543 to Jakafi®

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

March 31, 2017

Conditions
Healthy
Interventions
DRUG

CTP-543, 16 mg (2 x 8 mg tablet)

DRUG

Jakafi 15Mg Tablet

Trial Locations (1)

Unknown

Phoenix

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT02960945 - Open-Label Crossover Study Comparing CTP-543 to Jakafi® | Biotech Hunter | Biotech Hunter